Şok İndeksinin Çoklu Damar Hastalığı Saptanan Akut Koroner Sendrom Hastalarındaki Hastane İçi Mortaliteyi Öngördürücü Değeri
PDF

Orijinal Araştırma

Şok İndeksinin Çoklu Damar Hastalığı Saptanan Akut Koroner Sendrom Hastalarındaki Hastane İçi Mortaliteyi Öngördürücü Değeri

Bull Cardiovasc Acad 2024;2(3):76-83 DOI: 10.4274/kvbulten.galenos.2025.20592
,
PDF
İzin

Öz

Amaç

Biz bu çalışmamızda akut koroner sendromlu olgularda çok damar hastalığı saptanan durumlar da şok indeksinin hastane içi mortalite üzerine olan etkisini değerlendirmek istedik.

Yöntem ve Gereçler

Çalışmamıza akut koroner sendrom tanısı alan, çok damar hastalığı saptanan ve koroner anjiyografi ve primer perkütan koroner girişim ya da koroner arter by-pass cerrahisi yolu ile tedavi edilen 623 hasta dahil edildi. Şok indeksi kalp hızını sistolik kan basıncına bölerek hesaplandı.

Bulgular

Mortalite saptanan olgularda istatistiksel olarak kan basıncı daha düşüktü ve kalp hızı diğer gruba kıyasla daha yüksekti (p<0,001). Çok değişkenli Cox regresyonan alizinde yaş, düşük sol ventrikül ejeksiyon fraksiyonu, yüksek anatomik SYNTAX skoru ve şok indeksi hastane içi ölüm için öngördürücü olarak bulundu. Alıcı işletim karakteristik eğrisi analizinde şok indeksinin yeterli derecede mortalite öngördürücü istatistiksel gücü olduğu tesbit edildi (eğri altındaki alan: 0,711, %95 güven aralığı: 0,632-0,789, p<0,001).

Sonuç

Şok indeksi akut koroner sendromlu çok damar hastalığı olgularında mortalite öngördürücüsü olarak saptanmıştır.

Anahtar Kelimeler: Şok indeks, akut koroner sendrom, mortalite

Kaynakça

1

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826. Erratum in: Eur Heart J. 2024;45(13):1145.

2

Shiyovich A, Shlomo N, Cohen T, Iakobishvili Z, Kornowski R, Eisen A. Temporal trends of patients with acute coronary syndrome and multi-vessel coronary artery disease - from the ACSIS registry. Int J Cardiol. 2020;304:8-13.

3

Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28(14):1709-1716.

4

Toma M, Buller CE, Westerhout CM, Fu Y, O’Neill WW, Holmes DR Jr, et al. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J. 2010;31(14):1701-1707.

5

Park DW, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014;312(19):2019-2027.

6

Bianchini E, Basile M, Bianchini F, Zito A, Romagnoli E, Aurigemma C, et al. Multivessel revascularization in non-ST segment elevation acute coronary syndromes: a systematic review and meta-analysis of 182,798 patients. Int J Cardiol. 2024;413:132392.

7

Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Intern Med. 2014;174(2):223-230.

8

Stähli BE, Varbella F, Linke A, Schwarz B, Felix SB, Seiffert M, et al. Timing of complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med. 2023;389(15):1368-1379.

9

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-972. Erratum in: N Engl J Med. 2013;368(6):584.

10

Aggarwal V, Rajpathak S, Singh M, Romick B, Srinivas VS. Clinical outcomes based on completeness of revascularisation in patients undergoing percutaneous coronary intervention: a meta-analysis of multivessel coronary artery disease studies. EuroIntervention. 2012;7(9):1095-1102.

11

Mariani J, Macchia A, De Abreu M, Gonzalez Villa Monte G, Tajer C. Multivessel versus single vessel angioplasty in non-ST elevation acute coronary syndromes: a systematic review and metaanalysis. PLoS One. 2016;11(2):e0148756.

12

Desperak P, Hawranek M, Gąsior P, Desperak A, Lekston A, Gąsior M. Long-term outcomes of patients with multivessel coronary artery disease presenting non-ST-segment elevation acute coronary syndromes. Cardiol J. 2019;26(2):157-168.

13

Kobayashi A, Misumida N, Luger D, Kanei Y. Shock Index as a predictor for In-hospital mortality in patients with non-ST-segment elevation myocardial infarction. Cardiovasc Revasc Med. 2016;17(4):225-228.

14

Huang B, Yang Y, Zhu J, Liang Y, Tan H, Yu L, et al. Usefulness of the admission shock index for predicting short-term outcomes in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2014;114(9):1315-1321.

15

Zhang X, Wang Z, Wang Z, Fang M, Shu Z. The prognostic value of shock index for the outcomes of acute myocardial infarction patients: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(38):e8014.

16

Jensen MT, Pereira M, Araujo C, Malmivaara A, Ferrieres J, Degano IR, et al. Heart rate at admission is a predictor of in-hospital mortality in patients with acute coronary syndromes: Results from 58 European hospitals: The European Hospital Benchmarking by Outcomes in acute coronary syndrome Processes study. Eur Heart J AcuteCardiovasc Care. 2018;7(2):149-157.

17

Bangalore S, Messerli FH, Ou FS, Tamis-Holland J, Palazzo A, Roe MT, et al. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. Eur Heart J. 2010;31(5):552-560.

18

Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP; PROVE IT-TIMI 22 Trial Investigators. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010;122(21):2142-2151.

19

Yang CH, Hsieh MJ, Chen CC, Wang CY, Chang SH, Lee CH, et al. The prognostic significance of SYNTAX score after early percutaneous transluminal coronary angioplasty for acute ST elevation myocardial infarction. Heart Lung Circ. 2013;22(5):341-345.

20

McNamara RL, Kennedy KF, Cohen DJ, Diercks DB, Moscucci M, Ramee S, et al. Predicting in-hospital mortality in patients with acute myocardial infarction. J Am Coll Cardiol. 2016;68(6):626-635. Erratum in: J Am Coll Cardiol. 2018;71(9):1060-1061.

21

Bosch X, Théroux P. Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2005;150(2):215-220.

22

Allgöwer M, Burri C. “Schockindex”. Dtsch Med Wochenschr 1967;92(43):1947-1950.

23

Koch E, Lovett S, Nghiem T, Riggs RA, Rech MA. Shock index in the emergency department: utility and limitations. Open Access Emerg Med. 2019;11:179-199.